• 2024
  Fert I, Douguet L, Vesin B, Moncoq F, Noirat A, Authié P, Ciret S, Le Chevalier F, Blanc C, Vitrenko Y, Charneau P, Majlessi L, Anna F, T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector., NPJ Vaccines 2024 Jun; 9(1): 102.
• 2024
  Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N, A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
• 2023
  Douguet L, Fert I, Lopez J, Vesin B, Le Chevalier F, Moncoq F, Authié P, Nguyen TM, Noirat A, Névo F, Blanc C, Bourgine M, Hardy D, Anna F, Majlessi L, Charneau P, Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine., EMBO Mol Med 2023 Sep; (): e17723.
• 2023
  Le Chevalier F, Authié P, Chardenoux S, Bourgine M, Vesin B, Cussigh D, Sassier Y, Fert I, Noirat A, Nemirov K, Anna F, Bérard M, Guinet F, Hardy D, Charneau P, Lemonnier F, Langa-Vives F, Majlessi L, Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication., Microbes Infect 2023 Apr; (): 105142.
• 2023
  Nemirov K, Authié P, Souque P, Moncoq F, Noirat A, Blanc C, Bourgine M, Majlessi L, Charneau P, Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses., Front Immunol 2023 ; 14(): 1208041.
• 2022
  Benjamin Vesin 1 , Pierre Authié 1 , Catherine Blanc 1 , Ingrid Fert 1 , Amandine Noirat 1 , Fabien Le Chevalier 1 , Yu Wei 1 , Min-Wen Ku 1 , Kirill Nemirov 1 , François Anna 1 , David Hardy 2 , Cyril Planchais 3 , Hugo Mouquet 3 , Françoise Guinet 4 , Pierre Charneau 1 , Laleh Majlessi 1 , Maryline Bourgine 1, Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters, Vaccines (Basel).
• 2022
  Anna F, Lopez J, Moncoq F, Blanc C, Authié P, Noirat A, Fert I, Souque P, Nevo F, Pawlik A, Hardy D, Goyard S, Hudrisier D, Brosch R, Guinet F, Neyrolles O, Charneau P, Majlessi L, , A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity., Mucosal Immunol 2022 Sep; (): .
• 2022
  Lopez J, Anna F, Authié P, Pawlik A, Ku MW, Blanc C, Souque P, Moncoq F, Noirat A, Hardy D, Sougakoff W, Brosch R, Guinet F, Charneau P, Majlessi L, , A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity., Cell Rep 2022 Jul; 40(4): 111142.
• 2022
  Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, , , Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H, Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
• 2022
  Vesin B, Lopez J, Noirat A, Authié P, Fert I, Le Chevalier F, Moncoq F, Nemirov K, Blanc C, Planchais C, Mouquet H, Guinet F, Hardy D, Vives FL, Gerke C, Anna F, Bourgine M, Majlessi L, Charneau P, , An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa., Mol Ther 2022 Apr; (): .
• 2022
  Di Gioacchino A, Legendre R, Rahou Y, Najburg V, Charneau P, Greenbaum BD, Tangy F, van der Werf S, Cocco S, Komarova AV, sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs., RNA 2022 Mar; 28(3): 277-289.
• 2021
  Ku MW, Authié P, Bourgine M, Anna F, Noirat A, Moncoq F, Vesin B, Nevo F, Lopez J, Souque P, Blanc C, Fert I, Chardenoux S, Lafosse L, Cussigh D, Hardy D, Nemirov K, Guinet F, Langa Vives F, Majlessi L, Charneau P, , Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice., EMBO Mol Med 2021 12; 13(12): e14459.
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Le Vu S, Jones G, Anna F, Rose T, Richard JB, Bernard-Stoecklin S, Goyard S, Demeret C, Helynck O, Escriou N, Gransagne M, Petres S, Robin C, Monnet V, Perrin de Facci L, Ungeheuer MN, Léon L, Guillois Y, Filleul L, Charneau P, Lévy-Bruhl D, van der Werf S, Noel H, , Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance., Nat Commun 2021 05; 12(1): 3025.
• 2021
  Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T, , Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
• 2021
  Arnaud Fontanet, Laura Tondeur, Rebecca Grant, Sarah Temmam, Yoann Madec, Thomas Bigot, Ludivine Grzelak, Isabelle Cailleau, Camille Besombes, Marie-Noëlle Ungeheuer, Charlotte Renaudat, Blanca Liliana Perlaza, Laurence Arowas, Nathalie Jolly, Sandrine Fernandes Pellerin, Lucie Kuhmel, Isabelle Staropoli, Christèle Huon, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Sandie Munier, Pierre Charneau, Caroline Demeret, Timothée Bruel, Marc Eloit, Olivier Schwartz, Bruno Hoen, SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020, Eurosurveillance, 2021, 26 (15), pp.2001695. ⟨10.2807/1560-7917.es.2021.26.15.2001695⟩.
• 2021
  Anna F, Goyard S, Lalanne AI, Nevo F, Gransagne M, Souque P, Louis D, Gillon V, Turbiez I, Bidard FC, Gobillion A, Savignoni A, Guillot-Delost M, Dejardin F, Dufour E, Petres S, Richard-Le Goff O, Choucha Z, Helynck O, Janin YL, Escriou N, Charneau P, Perez F, Rose T, Lantz O, , High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris., Eur J Immunol 2021 01; 51(1): 180-190.
• 2020
  Ku MW, Bourgine M, Authié P, Lopez J, Nemirov K, Moncoq F, Noirat A, Vesin B, Nevo F, Blanc C, Souque P, Tabbal H, Simon E, Hardy D, Le Dudal M, Guinet F, Fiette L, Mouquet H, Anna F, Martin A, Escriou N, Majlessi L, Charneau P, , Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models., Cell Host Microbe 2021 Feb 10;29(2):236-249: .
• 2020
  Ludivine Grzelak, Sarah Temmam, Cyril Planchais, Caroline Demeret, Laura Tondeur, Christèle Huon, Florence Guivel-Benhassine, Isabelle Staropoli, Maxime Chazal, Jeremy Dufloo, Delphine Planas, Julian Buchrieser, Maaran Michael Rajah, Remy Robinot, Françoise Porrot, Mélanie Albert, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Flora Donati, François Anna, Philippe Souque, Marion Gransagne, Jacques Bellalou, Mireille Nowakowski, Marija Backovic, Lila Bouadma, Lucie Le Fevre, Quentin Le Hingrat, Diane Descamps, Annabelle Pourbaix, Cédric Laouénan, Jade Ghosn, Yazdan Yazdanpanah, Camille Besombes, Nathalie Jolly, Sandrine Pellerin-Fernandes, Olivia Cheny, Marie-Noëlle Ungeheuer, Guillaume Mellon, Pascal Morel, Simon Rolland, Felix Rey, Sylvie Behillil, Vincent Enouf, Audrey Lemaitre, Marie-Aude Créach, Stéphane Pêtres, Nicolas Escriou, Pierre Charneau, Arnaud Fontanet, Bruno Hoen, Timothée Bruel, Marc Eloit, Hugo Mouquet, Olivier Schwartz, Sylvie van Der Werf, A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, 2020, 12 (559), pp.eabc3103. ⟨10.1126/scitranslmed.abc3103⟩.
• 2020
  Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, Staropoli I, Anna F, Souque P, Fernandes-Pellerin S, Jolly N, Renaudat C, Ungeheuer MN, Schmidt-Mutter C, Collongues N, Bolle A, Velay A, Lefebvre N, Mielcarek M, Meyer N, Rey D, Charneau P, Hoen B, De Seze J, Schwartz O, Fontanet A, , Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France., EBioMedicine 2020 Sep; 59(): 102915.
• 2020
  Blanco-Rodriguez G, Gazi A, Monel B, Frabetti S, Scoca V, Mueller F, Schwartz O, Krijnse-Locker J, Charneau P, Di Nunzio F, , Remodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes., J Virol 2020 05; 94(11): .
• 2018
  Sayes F, Blanc C, Ates LS, Deboosere N, Orgeur M, Le Chevalier F, Gröschel MI, Frigui W, Song OR, Lo-Man R, Brossier F, Sougakoff W, Bottai D, Brodin P, Charneau P, Brosch R, Majlessi L, Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors, Cell Rep 2018 Apr;23(4):1072-1084.
• 2015
  de Wispelaere M, Ricklin M, Souque P, Frenkiel MP, Paulous S, Garcìa-Nicolàs O, Summerfield A, Charneau P, Desprès P, A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs, PLoS Negl Trop Dis 2015 Oct;9(10):e0004081.
• 2015
  Lelek M, Casartelli N, Pellin D, Rizzi E, Souque P, Severgnini M, Di Serio C, Fricke T, Diaz-Griffero F, Zimmer C, Charneau P, Di Nunzio F, , Chromatin organization at the nuclear pore favours HIV replication., Nat Commun 2015 Mar; 6(): 6483.
• 2015
  Pol JG, Lekbaby B, Redelsperger F, Klamer S, Mandouri Y, Ahodantin J, Bieche I, Lefevre M, Souque P, Charneau P, Gadessaud N, Kremsdorf D, Soussan P, Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-α-stimulated signaling pathways and limits the extent of liver inflammation, FASEB J. 2015 May;29(5):1879-89.
• 2014
  Fernandez J, Portilho DM, Danckaert A, Munier S, Becker A, Roux P, Zambo A, Shorte S, Jacob Y, Vidalain PO, Charneau P, Clavel F, Arhel NJ, Microtubule-associated proteins 1 (MAP1) promote human immunodeficiency virus type I (HIV-1) intracytoplasmic routing to the nucleus, J. Biol. Chem. 2015 Feb;290(8):4631-46.
• 2014
  Rivière J, Hauer J, Poirot L, Brochet J, Souque P, Mollier K, Gouble A, Charneau P, Fischer A, Pâques F, de Villartay JP, Cavazzana M, Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells, Gene Ther. 2014 May;21(5):529-32.
• 2014
  Si-Tahar M, Blanc F, Furio L, Chopy D, Balloy V, Lafon M, Chignard M, Fiette L, Langa F, Charneau P, Pothlichet J, Protective role of LGP2 in influenza virus pathogenesis, J. Infect. Dis. 2014 Jul;210(2):214-23.
• 2011
  Iglesias C, Ringeard M, Di Nunzio F, Fernandez J, Gaudin R, Souque P, Charneau P, Arhel N, , Residual HIV-1 DNA Flap-independent nuclear import of cPPT/CTS double mutant viruses does not support spreading infection., Retrovirology 2011 Nov; 8(): 92.
• 2011
  Calderón-Gómez E, Lampropoulou V, Shen P, Neves P, Roch T, Stervbo U, Rutz S, Kühl AA, Heppner FL, Loddenkemper C, Anderton SM, Kanellopoulos JM, Charneau P, Fillatreau S, Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis, Eur. J. Immunol. 2011 Jun;41(6):1696-708.
• 2011
  Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, Ermonval M, Larquet E, Charneau P, Krey T, Mégret F, Guittet E, Rey FA, Flamand M, Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein, Proc. Natl. Acad. Sci. U.S.A. 2011 May;108(19):8003-8.
• 2010
  Rusakiewicz S, Dosset M, Mollier K, Souque P, Charneau P, Wain-Hobson S, Langlade-Demoyen P, Adotévi O, Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice, Vaccine 2010 Aug;28(38):6374-81.
• 2009
  Beignon AS, Mollier K, Liard C, Coutant F, Munier S, Rivière J, Souque P, Charneau P, Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques, J. Virol. 2009 Nov;83(21):10963-74.
• 2009
  Arhel NJ, Charneau P, Bisarsenical labeling of HIV-1 for real-time fluorescence microscopy, Methods Mol. Biol. 2009;485:151-9.
• 2008
  Coutant F, Frenkiel MP, Despres P, Charneau P, Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine, PLoS ONE 2008;3(12):e3973.
• 2008
  Alonso M, Ortega-Pérez I, Grubb MS, Bourgeois JP, Charneau P, Lledo PM, Turning astrocytes from the rostral migratory stream into neurons: a role for the olfactory sensory organ., J Neurosci 2008 Oct; 28(43): 11089-102.
• 2008
  Arhel NJ, Nisole S, Carthagena L, Coutant F, Souque P, Brussel A, Estaquier J, Charneau P, Lack of endogenous TRIM5alpha-mediated restriction in rhesus macaque dendritic cells, Blood 2008 Nov;112(9):3772-6.
• 2007
  Arhel NJ, Souquere-Besse S, Munier S, Souque P, Guadagnini S, Rutherford S, Prévost MC, Allen TD, Charneau P, HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore, EMBO J. 2007 Jun;26(12):3025-37.
• 2007
  Iglesias MC, Mollier K, Beignon AS, Souque P, Adotevi O, Lemonnier F, Charneau P, Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo, Mol. Ther. 2007 Jun;15(6):1203-10.
• 2006
  Breiman A, Vitour D, Vilasco M, Ottone C, Molina S, Pichard L, Fournier C, Delgrange D, Charneau P, Duverlie G, Wychowski C, Maurel P, Meurs EF, A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells, J. Gen. Virol. 2006 Dec;87(Pt 12):3587-98.
• 2006
  Arhel N, Genovesio A, Kim KA, Miko S, Perret E, Olivo-Marin JC, Shorte S, Charneau P, Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes, Nat. Methods 2006 Oct;3(10):817-24.
• 2006
  Arhel N, Munier S, Souque P, Mollier K, Charneau P, Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type, J. Virol. 2006 Oct;80(20):10262-9.
• 2006
  Arhel NJ, Souquere-Besse S, Charneau P, Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels, Retrovirology 2006;3:38.
• 2006
  Iglesias MC, Frenkiel MP, Mollier K, Souque P, Despres P, Charneau P, A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus, J Gene Med 2006 Mar;8(3):265-74.
• 2005
  Rohrlich PS, Fazilleau N, Ginhoux F, Firat H, Michel F, Cochet M, Laham N, Roth MP, Pascolo S, Nato F, Coppin H, Charneau P, Danos O, Acuto O, Ehrlich R, Kanellopoulos J, Lemonnier FA, Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function, Proc. Natl. Acad. Sci. U.S.A. 2005 Sep;102(36):12855-60.
• 2004
  Mordelet E, Kissa K, Cressant A, Gray F, Ozden S, Vidal C, Charneau P, Granon S, Histopathological and cognitive defects induced by Nef in the brain, FASEB J. 2004 Dec;18(15):1851-61.
• 2004
  Galetto R, Moumen A, Giacomoni V, Véron M, Charneau P, Negroni M, The structure of HIV-1 genomic RNA in the gp120 gene determines a recombination hot spot in vivo, J. Biol. Chem. 2004 Aug;279(35):36625-32.
• 2004
  Strick-Marchand H, Morosan S, Charneau P, Kremsdorf D, Weiss MC, Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes, Proc. Natl. Acad. Sci. U.S.A. 2004 Jun;101(22):8360-5.
• 2004
  Lorin C, Mollet L, Delebecque F, Combredet C, Hurtrel B, Charneau P, Brahic M, Tangy F, A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV, J. Virol. 2004 Jan;78(1):146-57.
• 2003
  Amara A, Vidy A, Boulla G, Mollier K, Garcia-Perez J, Alcamí J, Blanpain C, Parmentier M, Virelizier JL, Charneau P, Arenzana-Seisdedos F, G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates, J. Virol. 2003 Feb;77(4):2550-8.
• 2002
  Royer-Leveau C, Mordelet E, Delebecque F, Gessain A, Charneau P, Ozden S, Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector, J. Virol. Methods 2002 Aug;105(1):133-40.